Feed aggregator

Amgen Lays Off 350 Employees Following $27.8B Horizon Acquisition

Biospace news - Wed, 10/25/2023 - 02:00
Amgen Lays Off 350 Employees Following $27.8B Horizon Acquisition 10/25/2023

Servier’s Tibsovo Gets FDA Approval as First Targeted Therapy for MDS

Biospace news - Wed, 10/25/2023 - 02:00
Servier’s Tibsovo Gets FDA Approval as First Targeted Therapy for MDS 10/25/2023

Novartis Builds Case for Earlier Prostate Cancer Treatment with Phase III Data

Biospace news - Tue, 10/24/2023 - 02:00
Novartis Builds Case for Earlier Prostate Cancer Treatment with Phase III Data 10/24/2023

Roche Pays $7.1B to Roivant for Rights to Telavant’s IBD Candidate

Biospace news - Mon, 10/23/2023 - 02:00
Roche Pays $7.1B to Roivant for Rights to Telavant’s IBD Candidate 10/23/2023

Merck, BMS Score Separate Late-Stage Victories in Bladder Cancer at ESMO

Biospace news - Mon, 10/23/2023 - 02:00
Merck, BMS Score Separate Late-Stage Victories in Bladder Cancer at ESMO 10/23/2023

FDA Approves BioMarin’s Voxzogo for Young Children with Dwarfism

Biospace news - Mon, 10/23/2023 - 02:00
FDA Approves BioMarin’s Voxzogo for Young Children with Dwarfism 10/23/2023

NASH on the Cusp: An Emerging Market Opportunity

Biospace news - Mon, 10/23/2023 - 02:00
NASH on the Cusp: An Emerging Market Opportunity 10/23/2023

Achieving Data Diversity Through AI in Drug Development

Biospace news - Mon, 10/23/2023 - 02:00
Achieving Data Diversity Through AI in Drug Development 10/23/2023

Opinion: The Potential of Neurofilament Light Chain as a Biomarker in Parkinson’s Disease

Biospace news - Mon, 10/23/2023 - 02:00
Opinion: The Potential of Neurofilament Light Chain as a Biomarker in Parkinson’s Disease 10/23/2023

Biopharma Industry Continues to Bet Big on Antibody-Drug Conjugates

Biospace news - Fri, 10/20/2023 - 02:00
Biopharma Industry Continues to Bet Big on Antibody-Drug Conjugates 10/20/2023

Merck Pays $4B Upfront for Daiichi Sankyo’s DXd-Based ADCs

Biospace news - Fri, 10/20/2023 - 02:00
Merck Pays $4B Upfront for Daiichi Sankyo’s DXd-Based ADCs 10/20/2023

EU Antitrust Regulators Clear Pfizer’s $43B Acquisition of Seagen

Biospace news - Fri, 10/20/2023 - 02:00
EU Antitrust Regulators Clear Pfizer’s $43B Acquisition of Seagen 10/20/2023

Amgen’s T-Cell Engager Shows Phase II Promise in Tough to Treat Lung Cancer

Biospace news - Fri, 10/20/2023 - 02:00
Amgen’s T-Cell Engager Shows Phase II Promise in Tough to Treat Lung Cancer 10/20/2023

BMS Gets Phase III Victory for Subcutaneous Formulation of Opdivo in Kidney Cancer

Biospace news - Fri, 10/20/2023 - 02:00
BMS Gets Phase III Victory for Subcutaneous Formulation of Opdivo in Kidney Cancer 10/20/2023

Flagship’s Laronde, Senda Form Company Focused on New Class of Medicines

Biospace news - Fri, 10/20/2023 - 02:00
Flagship’s Laronde, Senda Form Company Focused on New Class of Medicines 10/20/2023

ESMO Abstract Leak Reveals Promising NSCLC Therapies from BMS, BeiGene, J&J, ...

Biospace news - Wed, 10/18/2023 - 02:00
ESMO Abstract Leak Reveals Promising NSCLC Therapies from BMS, BeiGene, J&J, ... 10/18/2023

BrainStorm Withdraws BLA for ALS Therapy, Plans Phase IIIb Trial

Biospace news - Wed, 10/18/2023 - 02:00
BrainStorm Withdraws BLA for ALS Therapy, Plans Phase IIIb Trial 10/18/2023

Ardelyx Nabs FDA Approval for First Phosphate Absorption Blocker in CKD

Biospace news - Wed, 10/18/2023 - 02:00
Ardelyx Nabs FDA Approval for First Phosphate Absorption Blocker in CKD 10/18/2023

Ultimovacs Rebounds on New Universal Cancer Vaccine Data for Mesothelioma

Biospace news - Wed, 10/18/2023 - 02:00
Ultimovacs Rebounds on New Universal Cancer Vaccine Data for Mesothelioma 10/18/2023

FDA Approves UCB’s Complement Inhibitor for Generalized Myasthenia Gravis

Biospace news - Wed, 10/18/2023 - 02:00
FDA Approves UCB’s Complement Inhibitor for Generalized Myasthenia Gravis 10/18/2023